Assessing heparin dosing in neonates on venoarterial extracorporeal membrane oxygenation

ASAIO Journal

Volumn 53, Issue 1, 2007, Pages 111-114

  Nankervis, Craig A ^a,c   Preston, Thomas J ^a   Dysart, Kevin C ^a   Wilkinson, Whitney D ^a   Chicoine, Louis G ^a,c   Welty, Stephen E ^a   Nelin, Leif D ^a,b,c,d  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d Center for Perinatal Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-THROMBIN; DRIP RATE; NEONATAL PATIENTS;

BIOMEDICAL ENGINEERING; BLOOD; CARDIOVASCULAR SYSTEM; DIAGNOSIS; PATIENT TREATMENT;

PATIENT MONITORING;

AUTOANTIBODY; BLOOD CLOTTING FACTOR 10A ANTIBODY; HEPARIN; THROMBIN INHIBITOR; UNCLASSIFIED DRUG;

ANTICOAGULATION; ARTICLE; BLOOD CLOTTING TIME; CLINICAL ARTICLE; CLINICAL TRIAL; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG ACCUMULATION; EXTRACORPOREAL OXYGENATION; HUMAN; NEWBORN;

ANTICOAGULANTS; ANTITHROMBIN III; EXTRACORPOREAL MEMBRANE OXYGENATION; HEPARIN; HUMANS; INFANT, NEWBORN; LINEAR MODELS; WHOLE BLOOD COAGULATION TIME;

EID: 33846426857     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mat.0000247777.65764.b3     Document Type: Article

References (10)

1. Bahrami KR, Van Meurs KP: ECMO for neonatal respiratory failure. Semin Perinatol 29: 15-23, 2005.
2. Zavadil DP, Stammers AH, Willett LD, et al: Hematological abnormalities in neonatal patients treated with extracorporeal membrane oxygenation (ECMO). J Extra Corpor Technol 30: 83-90, 1998.
3. Green TP, Isham-Schopf B, Steinhorn RH, et al: Whole blood activated clotting time in infants during extracorporeal membrane oxygenation. Crit Care Med 18: 494-498, 1990.
4. Muntean W: Coagulation and anticoagulation in extracorporeal membrane oxygenation. Artif Organs 23: 979-83, 1999.
5. Colby CE, Sheehan A, Benitz W, et al: Maintaining adequate anticoagulation on extracorporeal membrane oxygenation therapy: Hemochron Junior Low Range versus Hemochron 400. J Extra Corpor Technol 35: 35-38, 2003.
6. Ambrose TM, Parvin CA, Mendeloff E, Luchtman-Jones L: Evaluation of the TAS analyzer and the low-range heparin management test in patients undergoing extracorporeal membrane oxygenation. Clin Chem 47: 858-866, 2001.
7. Graves DF, Chernin JM, Kurusz M, Zwischenberger JB: Anticoagulation practices during neonatal extracorporeal membrane oxygenation: survey results. Perfusion 11: 461-466, 1996.
8. Urlesberger B, Zobel G, Zenz W, et al: Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infants. J Pediatr 129: 264-268, 1996.
9. Buck ML: Pharmacokinetic changes during extracorporeal membrane oxygenation implications for drug therapy in neonates. Clin Pharmacokinet 42: 403-417, 2003.
10. Green TP, Isham-Schopf B, Irmiter RJ, et al: Inactivation of heparin during extracorporeal circulation in infants. Clin Pharmacol Ther 48: 148-154, 1990.